Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Gray

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
European Heart Journal|June 7, 2024
Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yetGemma A Figtree, Michael P Gray
The Medical Journal of Australia|October 8, 2024
Genetic testing in cardiovascular diseaseMichael P Gray, Gemma A Figtree
Climacteric : the Journal of the International Menopause Society|May 16, 2025
Heart matters: the unique landscape of cardiovascular health in womenGemma A Figtree, Michael P Gray
Pulmonary Circulation|June 12, 2015
Participant expectations in pulmonary hypertension-related research studiesMichael P Gray, Rino Aldrighetti, Karen A Fagan
Heart, Lung & Circulation|February 8, 2026
Shifting the Paradigm: Bringing Personalised Approaches to Coronary Artery DiseaseSina Fathieh, Michael P Gray, Gemma A Figtree
The New England Journal of Medicine|December 20, 2023
Modifiable Risk Factors and Cardiovascular OutcomesGemma A Figtree, Michael P Gray, Keith M Channon
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|February 2, 2017
Why do team-sport athletes drink fluid in excess when exercising in cool conditions?Melissa J Bargh, Roderick F G J King, Michael P Gray, et al.
The Medical Journal of Australia|April 4, 2024
Genetic testing in cardiovascular diseaseMichael P Gray, Diane Fatkin, Jodie Ingles, et al.
Atherosclerosis|January 23, 2026
Coronary artery disease in the absence of standard modifiable risk factors (SMuRFs): The impact of sexDaniel G Brieger, Michael P Gray, Sina Fathieh, et al.
Pulmonary Circulation|March 15, 2018
Overdue to understand anticoagulation in pulmonary arterial hypertensionKishan S Parikh, Michael P Gray, Lewis J Rubin, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
European Heart Journal|June 7, 2024
Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yetGemma A Figtree, Michael P Gray
The Medical Journal of Australia|October 8, 2024
Genetic testing in cardiovascular diseaseMichael P Gray, Gemma A Figtree
Climacteric : the Journal of the International Menopause Society|May 16, 2025
Heart matters: the unique landscape of cardiovascular health in womenGemma A Figtree, Michael P Gray
Pulmonary Circulation|June 12, 2015
Participant expectations in pulmonary hypertension-related research studiesMichael P Gray, Rino Aldrighetti, Karen A Fagan
Heart, Lung & Circulation|February 8, 2026
Shifting the Paradigm: Bringing Personalised Approaches to Coronary Artery DiseaseSina Fathieh, Michael P Gray, Gemma A Figtree
The New England Journal of Medicine|December 20, 2023
Modifiable Risk Factors and Cardiovascular OutcomesGemma A Figtree, Michael P Gray, Keith M Channon
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|February 2, 2017
Why do team-sport athletes drink fluid in excess when exercising in cool conditions?Melissa J Bargh, Roderick F G J King, Michael P Gray, et al.
The Medical Journal of Australia|April 4, 2024
Genetic testing in cardiovascular diseaseMichael P Gray, Diane Fatkin, Jodie Ingles, et al.
Atherosclerosis|January 23, 2026
Coronary artery disease in the absence of standard modifiable risk factors (SMuRFs): The impact of sexDaniel G Brieger, Michael P Gray, Sina Fathieh, et al.
Pulmonary Circulation|March 15, 2018
Overdue to understand anticoagulation in pulmonary arterial hypertensionKishan S Parikh, Michael P Gray, Lewis J Rubin, et al.
Pageof 4